Pharma

By Laura Lovett May 16, 2018
DNA, health records, and blood test results are not only intimately personal, they are also a valuable asset to researchers. Recently a smattering of companies have been working to create a market for people to share and sell their personal data to researchers and healthcare players. Those efforts are going one step further, as two growing names in the health data and blockchain industry are...
By Dave Muoio May 14, 2018
Verily researchers have built prototype devices for painless blood collection that uses a system of “exploding” micro-needles, magnets, and potentially a blood storage chamber, CNBC reports. Information on the device was received from several anonymous sources, who CNBC said did not want to be named as the project is still unannounced. “Several sources aware of the company's plans say the device...
By Dave Muoio May 3, 2018
Garmin and the University of Kansas Medical Center are taking a closer look at the role wearables can play in detecting and managing medical conditions, the groups announced earlier this week. Initially focused on sleep apnea and atrial fibrillation, the collaboration is a clear step beyond the fitness and wellness realm to which Garmin’s wearables have so far been limited. “Garmin Health is...
By Dave Muoio May 2, 2018
In a recent medium.com blog post, Daphne Koller — an artificial intelligence researcher at the Department of Computer Science at Stanford University and, until just a few months ago, chief computing officer at Alphabet’s Calico Labs — announced her up-and-coming foray into machine learning-powered drug discovery. Called insitro (a portmanteau of “in silico” and “in vitro”), the new endeavor looks...
By Laura Lovett April 25, 2018
Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends. Recently big pharma has been looking to artificial intelligence as another tool to help facilitate drug research and help the company progress.  At the World Medical Innovation Forum in Boston on April 24, a panel of pharma leaders discussed the future of AI in the industry.  “It's quite top...
By Dave Muoio April 19, 2018
Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler. Launched in 2016, the web- and mobile-based RespiPoints program offers patients a variety of adherence-...
By MobiHealthNews April 13, 2018
Pharma companies have been eying digital health with interest, and the first quarter of 2018 was no exception. With the exception of some medication adherence-focused technologies — such as an edible QR code intended to assist with medication dosing — news tended to center around digitally-enabled clinical trials, rollouts or pilots of pharma-focused digital tools, and major deals or...
By Dave Muoio April 12, 2018
ActiGraph activity monitors and a mobile app from Clinical Ink are are at the heart of a newly announced pilot study backed by Bayer, according to a statement released today by ActiGraph. The ongoing study is evaluating how these digital products and a Bluetooth-enabled weight scale are perceived by patients, and the feasibility of implementing such devices in future clinical trials run by the...
By Susan Morse April 4, 2018
Five healthcare organizations including insurers UnitedHealthcare and Humana, Optum, Quest Diagnostics, and MultiPlan are launching a blockchain pilot to help payers tackle mandated provider directories. UnitedHealthcare and Optum are both part of UnitedHealth Group. Humana got involved through old-fashioned networking, according to Mike Jacobs, a senior distinguished engineer at Optum, who has...
By Dave Muoio April 4, 2018
Pfizer announced today that it is receiving applications for its Pfizer Healthcare Hub: London competitive grant. This is the second time that Pfizer has held the startup-focused program, which representatives from biopharmaceutical company said had a strong inaugural year in 2017. “Following the success of the 2017 UK Hub, I’m delighted to continue the program again this year,” Erik Nordkamp,...